These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1783992)

  • 1. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.
    Shen J; Wanwimolruk S; Purves RD; McQueen EG; Roberts MS
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):575-95. PubMed ID: 1783992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers.
    Day RO; Furst DE; Dromgoole SH; Paulus HE
    Biopharm Drug Dispos; 1988; 9(3):273-83. PubMed ID: 3395669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate clearance, the resultant of protein binding and metabolism.
    Furst DE; Tozer TN; Melmon KL
    Clin Pharmacol Ther; 1979 Sep; 26(3):380-9. PubMed ID: 466931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.
    Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG
    Eur J Clin Pharmacol; 1987; 32(2):153-8. PubMed ID: 3582479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate metabolite kinetics after several salicylates.
    Bochner F; Graham GG; Cham BE; Imhoff DM; Haavisto TM
    Clin Pharmacol Ther; 1981 Aug; 30(2):266-75. PubMed ID: 7249509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats.
    Yue TL; Varma DR
    Drug Metab Dispos; 1982; 10(2):147-52. PubMed ID: 6124400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of salicylic acid in malnourished Ethiopian children after single oral dose.
    Ashton M; Bolme P; Zerihun G; Holmberg K; Paalzow LK
    Clin Pharmacokinet; 1993 Dec; 25(6):483-94. PubMed ID: 8119048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and elimination of salicylic acid in rabbits.
    Short CR; Neff-Davis CA; Hsieh LC; Koritz GD; Malbrough MS; Barker SA; Davis LE
    J Vet Pharmacol Ther; 1991 Mar; 14(1):70-7. PubMed ID: 2038097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.
    Roberts MS; Rumble RH; Wanwimolruk S; Thomas D; Brooks PM
    Eur J Clin Pharmacol; 1983; 25(2):253-61. PubMed ID: 6628510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylate pharmacokinetics in patients with rheumatoid arthritis.
    Owen SG; Roberts MS; Friesen WT; Francis HW
    Br J Clin Pharmacol; 1989 Oct; 28(4):449-61. PubMed ID: 2590603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
    Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
    Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate metabolism: effects of age and sex in adults.
    Montgomery PR; Berger LG; Mitenko PA; Sitar DS
    Clin Pharmacol Ther; 1986 May; 39(5):571-6. PubMed ID: 3698465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.
    Singh P; Roberts MS
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):337-73. PubMed ID: 8133461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography.
    Liu JH; Smith PC
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):61-70. PubMed ID: 8634769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of aspirin after therapeutic and toxic doses.
    Patel DK; Hesse A; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 May; 9(3):131-6. PubMed ID: 2375880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats.
    Varma DR; Yue TL
    Br J Pharmacol; 1984 May; 82(1):241-8. PubMed ID: 6428498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
    Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
    J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.